Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 268

1.

Drugging MYCN oncogenic signalling through the MYCN-PA2G4 binding interface.

Koach J, Holien JK, Massudi H, Carter DR, Ciampa OC, Herath M, Lim T, Seneviratne JA, Milazzo G, Murray JE, McCarroll JA, Liu B, Mayoh C, Keenan B, Stevenson BW, Gorman MA, Bell JL, Doughty L, Hüttelmaier S, Oberthuer A, Fischer M, Gifford AJ, Liu T, Zhang X, Zhu S, Gustafson WC, Haber M, Norris MD, Fletcher JI, Perini G, Parker MW, Cheung BB, Marshall GM.

Cancer Res. 2019 Sep 9. pii: canres.1112.2019. doi: 10.1158/0008-5472.CAN-19-1112. [Epub ahead of print]

PMID:
31501192
2.

The Challenges and Possibilities of Extracellular Vesicles as Therapeutic Vehicles.

Melling GE, Carollo E, Conlon R, Simpson JC, Carter DRF.

Eur J Pharm Biopharm. 2019 Nov;144:50-56. doi: 10.1016/j.ejpb.2019.08.009. Epub 2019 Aug 13. Review.

PMID:
31419585
3.

An intergenic non-coding RNA promoter required for histone modifications in the human β-globin chromatin domain.

Debrand E, Chakalova L, Miles J, Dai YF, Goyenechea B, Dye S, Osborne CS, Horton A, Harju-Baker S, Pink RC, Caley D, Carter DRF, Peterson KR, Fraser P.

PLoS One. 2019 Aug 14;14(8):e0217532. doi: 10.1371/journal.pone.0217532. eCollection 2019.

4.

Increase in DNA Damage by MYCN Knockdown Through Regulating Nucleosome Organization and Chromatin State in Neuroblastoma.

Hu X, Zheng W, Zhu Q, Gu L, Du Y, Han Z, Zhang X, Carter DR, Cheung BB, Qiu A, Jiang C.

Front Genet. 2019 Jul 24;10:684. doi: 10.3389/fgene.2019.00684. eCollection 2019.

5.

Learning From the Past to Advance the Future: The Adaptation and Resilience of NASA's Spaceflight Multiteam Systems Across Four Eras of Spaceflight.

Pendergraft JG, Carter DR, Tseng S, Landon LB, Slack KJ, Shuffler ML.

Front Psychol. 2019 Jul 12;10:1633. doi: 10.3389/fpsyg.2019.01633. eCollection 2019.

6.

Heterozygous loss of keratinocyte TRIM16 expression increases melanocytic cell lesions and lymph node metastasis.

Sutton SK, Cheung BB, Massudi H, Tan O, Koach J, Mayoh C, Carter DR, Marshall GM.

J Cancer Res Clin Oncol. 2019 Sep;145(9):2241-2250. doi: 10.1007/s00432-019-02981-5. Epub 2019 Jul 24.

7.

Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017.

Clayton A, Buschmann D, Byrd JB, Carter DRF, Cheng L, Compton C, Daaboul G, Devitt A, Falcon-Perez JM, Gardiner C, Gustafson D, Harrison P, Helmbrecht C, Hendrix A, Hill A, Hoffman A, Jones JC, Kalluri R, Kang JY, Kirchner B, Lässer C, Lawson C, Lenassi M, Levin C, Llorente A, Martens-Uzunova ES, Möller A, Musante L, Ochiya T, Pink RC, Tahara H, Wauben MHM, Webber JP, Welsh JA, Witwer KW, Yin H, Nieuwland R.

J Extracell Vesicles. 2018 May 17;7(1):1473707. doi: 10.1080/20013078.2018.1473707. eCollection 2018.

8.

Clinical requirements for extracellular vesicle assays.

Ayers L, Pink R, Carter DRF, Nieuwland R.

J Extracell Vesicles. 2019 Mar 27;8(1):1593755. doi: 10.1080/20013078.2019.1593755. eCollection 2019. Review.

9.

Scope, Influence, and Interdisciplinary Collaboration: The Publication Portfolio of the NIH Clinical and Translational Science Awards (CTSA) Program From 2006 Through 2017.

Llewellyn N, Carter DR, DiazGranados D, Pelfrey C, Rollins L, Nehl EJ.

Eval Health Prof. 2019 Mar 27:163278719839435. doi: 10.1177/0163278719839435. [Epub ahead of print]

PMID:
30917690
10.

Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma.

Gamble LD, Purgato S, Murray J, Xiao L, Yu DMT, Hanssen KM, Giorgi FM, Carter DR, Gifford AJ, Valli E, Milazzo G, Kamili A, Mayoh C, Liu B, Eden G, Sarraf S, Allan S, Di Giacomo S, Flemming CL, Russell AJ, Cheung BB, Oberthuer A, London WB, Fischer M, Trahair TN, Fletcher JI, Marshall GM, Ziegler DS, Hogarty MD, Burns MR, Perini G, Norris MD, Haber M.

Sci Transl Med. 2019 Jan 30;11(477). pii: eaau1099. doi: 10.1126/scitranslmed.aau1099.

PMID:
30700572
11.

Detecting ovarian cancer using extracellular vesicles: progress and possibilities.

Carollo E, Paris B, Samuel P, Pantazi P, Bartelli TF, Dias-Neto E, Brooks SA, Pink RC, Carter DRF.

Biochem Soc Trans. 2019 Feb 28;47(1):295-304. doi: 10.1042/BST20180286. Epub 2019 Jan 30. Review.

PMID:
30700499
12.

Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines.

Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F, Atkin-Smith GK, Ayre DC, Bach JM, Bachurski D, Baharvand H, Balaj L, Baldacchino S, Bauer NN, Baxter AA, Bebawy M, Beckham C, Bedina Zavec A, Benmoussa A, Berardi AC, Bergese P, Bielska E, Blenkiron C, Bobis-Wozowicz S, Boilard E, Boireau W, Bongiovanni A, Borràs FE, Bosch S, Boulanger CM, Breakefield X, Breglio AM, Brennan MÁ, Brigstock DR, Brisson A, Broekman ML, Bromberg JF, Bryl-Górecka P, Buch S, Buck AH, Burger D, Busatto S, Buschmann D, Bussolati B, Buzás EI, Byrd JB, Camussi G, Carter DR, Caruso S, Chamley LW, Chang YT, Chen C, Chen S, Cheng L, Chin AR, Clayton A, Clerici SP, Cocks A, Cocucci E, Coffey RJ, Cordeiro-da-Silva A, Couch Y, Coumans FA, Coyle B, Crescitelli R, Criado MF, D'Souza-Schorey C, Das S, Datta Chaudhuri A, de Candia P, De Santana EF, De Wever O, Del Portillo HA, Demaret T, Deville S, Devitt A, Dhondt B, Di Vizio D, Dieterich LC, Dolo V, Dominguez Rubio AP, Dominici M, Dourado MR, Driedonks TA, Duarte FV, Duncan HM, Eichenberger RM, Ekström K, El Andaloussi S, Elie-Caille C, Erdbrügger U, Falcón-Pérez JM, Fatima F, Fish JE, Flores-Bellver M, Försönits A, Frelet-Barrand A, Fricke F, Fuhrmann G, Gabrielsson S, Gámez-Valero A, Gardiner C, Gärtner K, Gaudin R, Gho YS, Giebel B, Gilbert C, Gimona M, Giusti I, Goberdhan DC, Görgens A, Gorski SM, Greening DW, Gross JC, Gualerzi A, Gupta GN, Gustafson D, Handberg A, Haraszti RA, Harrison P, Hegyesi H, Hendrix A, Hill AF, Hochberg FH, Hoffmann KF, Holder B, Holthofer H, Hosseinkhani B, Hu G, Huang Y, Huber V, Hunt S, Ibrahim AG, Ikezu T, Inal JM, Isin M, Ivanova A, Jackson HK, Jacobsen S, Jay SM, Jayachandran M, Jenster G, Jiang L, Johnson SM, Jones JC, Jong A, Jovanovic-Talisman T, Jung S, Kalluri R, Kano SI, Kaur S, Kawamura Y, Keller ET, Khamari D, Khomyakova E, Khvorova A, Kierulf P, Kim KP, Kislinger T, Klingeborn M, Klinke DJ 2nd, Kornek M, Kosanović MM, Kovács ÁF, Krämer-Albers EM, Krasemann S, Krause M, Kurochkin IV, Kusuma GD, Kuypers S, Laitinen S, Langevin SM, Languino LR, Lannigan J, Lässer C, Laurent LC, Lavieu G, Lázaro-Ibáñez E, Le Lay S, Lee MS, Lee YXF, Lemos DS, Lenassi M, Leszczynska A, Li IT, Liao K, Libregts SF, Ligeti E, Lim R, Lim SK, Linē A, Linnemannstöns K, Llorente A, Lombard CA, Lorenowicz MJ, Lörincz ÁM, Lötvall J, Lovett J, Lowry MC, Loyer X, Lu Q, Lukomska B, Lunavat TR, Maas SL, Malhi H, Marcilla A, Mariani J, Mariscal J, Martens-Uzunova ES, Martin-Jaular L, Martinez MC, Martins VR, Mathieu M, Mathivanan S, Maugeri M, McGinnis LK, McVey MJ, Meckes DG Jr, Meehan KL, Mertens I, Minciacchi VR, Möller A, Møller Jørgensen M, Morales-Kastresana A, Morhayim J, Mullier F, Muraca M, Musante L, Mussack V, Muth DC, Myburgh KH, Najrana T, Nawaz M, Nazarenko I, Nejsum P, Neri C, Neri T, Nieuwland R, Nimrichter L, Nolan JP, Nolte-'t Hoen EN, Noren Hooten N, O'Driscoll L, O'Grady T, O'Loghlen A, Ochiya T, Olivier M, Ortiz A, Ortiz LA, Osteikoetxea X, Østergaard O, Ostrowski M, Park J, Pegtel DM, Peinado H, Perut F, Pfaffl MW, Phinney DG, Pieters BC, Pink RC, Pisetsky DS, Pogge von Strandmann E, Polakovicova I, Poon IK, Powell BH, Prada I, Pulliam L, Quesenberry P, Radeghieri A, Raffai RL, Raimondo S, Rak J, Ramirez MI, Raposo G, Rayyan MS, Regev-Rudzki N, Ricklefs FL, Robbins PD, Roberts DD, Rodrigues SC, Rohde E, Rome S, Rouschop KM, Rughetti A, Russell AE, Saá P, Sahoo S, Salas-Huenuleo E, Sánchez C, Saugstad JA, Saul MJ, Schiffelers RM, Schneider R, Schøyen TH, Scott A, Shahaj E, Sharma S, Shatnyeva O, Shekari F, Shelke GV, Shetty AK, Shiba K, Siljander PR, Silva AM, Skowronek A, Snyder OL 2nd, Soares RP, Sódar BW, Soekmadji C, Sotillo J, Stahl PD, Stoorvogel W, Stott SL, Strasser EF, Swift S, Tahara H, Tewari M, Timms K, Tiwari S, Tixeira R, Tkach M, Toh WS, Tomasini R, Torrecilhas AC, Tosar JP, Toxavidis V, Urbanelli L, Vader P, van Balkom BW, van der Grein SG, Van Deun J, van Herwijnen MJ, Van Keuren-Jensen K, van Niel G, van Royen ME, van Wijnen AJ, Vasconcelos MH, Vechetti IJ Jr, Veit TD, Vella LJ, Velot É, Verweij FJ, Vestad B, Viñas JL, Visnovitz T, Vukman KV, Wahlgren J, Watson DC, Wauben MH, Weaver A, Webber JP, Weber V, Wehman AM, Weiss DJ, Welsh JA, Wendt S, Wheelock AM, Wiener Z, Witte L, Wolfram J, Xagorari A, Xander P, Xu J, Yan X, Yáñez-Mó M, Yin H, Yuana Y, Zappulli V, Zarubova J, Žėkas V, Zhang JY, Zhao Z, Zheng L, Zheutlin AR, Zickler AM, Zimmermann P, Zivkovic AM, Zocco D, Zuba-Surma EK.

J Extracell Vesicles. 2018 Nov 23;7(1):1535750. doi: 10.1080/20013078.2018.1535750. eCollection 2018.

13.

LDHA in Neuroblastoma Is Associated with Poor Outcome and Its Depletion Decreases Neuroblastoma Growth Independent of Aerobic Glycolysis.

Dorneburg C, Fischer M, Barth TFE, Mueller-Klieser W, Hero B, Gecht J, Carter DR, de Preter K, Mayer B, Christner L, Speleman F, Marshall GM, Debatin KM, Beltinger C.

Clin Cancer Res. 2018 Nov 15;24(22):5772-5783. doi: 10.1158/1078-0432.CCR-17-2578. Epub 2018 Jun 20.

PMID:
29925504
14.

Teamwork situated in multiteam systems: Key lessons learned and future opportunities.

Shuffler ML, Carter DR.

Am Psychol. 2018 May-Jun;73(4):390-406. doi: 10.1037/amp0000322. Review.

PMID:
29792456
15.

Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCN.

Ooi CY, Carter DR, Liu B, Mayoh C, Beckers A, Lalwani A, Nagy Z, De Brouwer S, Decaesteker B, Hung TT, Norris MD, Haber M, Liu T, De Preter K, Speleman F, Cheung BB, Marshall GM.

Cancer Res. 2018 Jun 15;78(12):3122-3134. doi: 10.1158/0008-5472.CAN-17-3034. Epub 2018 Apr 2.

16.

Charting the Publication and Citation Impact of the NIH Clinical and Translational Science Awards (CTSA) Program From 2006 Through 2016.

Llewellyn N, Carter DR, Rollins L, Nehl EJ.

Acad Med. 2018 Aug;93(8):1162-1170. doi: 10.1097/ACM.0000000000002119.

17.

How Team Interlock Ecosystems Shape the Assembly of Scientific Teams: A Hypergraph Approach.

Lungeanu A, Carter DR, DeChurch LA, Contractor NS.

Commun Methods Meas. 2018;12(2-3):174-198. doi: 10.1080/19312458.2018.1430756. Epub 2018 Feb 20.

18.

Royal Society Scientific Meeting: Extracellular vesicles in the tumour microenvironment.

Pink RC, Elmusrati AA, Lambert D, Carter DRF.

Philos Trans R Soc Lond B Biol Sci. 2018 Jan 5;373(1737). pii: 20170066. doi: 10.1098/rstb.2017.0066. Review.

19.

Cisplatin induces the release of extracellular vesicles from ovarian cancer cells that can induce invasiveness and drug resistance in bystander cells.

Samuel P, Mulcahy LA, Furlong F, McCarthy HO, Brooks SA, Fabbri M, Pink RC, Carter DRF.

Philos Trans R Soc Lond B Biol Sci. 2018 Jan 5;373(1737). pii: 20170065. doi: 10.1098/rstb.2017.0065.

20.

Extracellular vesicles in the tumour microenvironment.

Carter DRF, Clayton A, Devitt A, Hunt S, Lambert DW.

Philos Trans R Soc Lond B Biol Sci. 2018 Jan 5;373(1737). pii: 20160475. doi: 10.1098/rstb.2016.0475. No abstract available.

21.

Mechanisms of Drug Resistance in Cancer: The Role of Extracellular Vesicles.

Samuel P, Fabbri M, Carter DRF.

Proteomics. 2017 Dec;17(23-24). doi: 10.1002/pmic.201600375. Epub 2017 Oct 25. Review.

PMID:
28941129
22.

Extracellular vesicles released following heat stress induce bystander effect in unstressed populations.

Bewicke-Copley F, Mulcahy LA, Jacobs LA, Samuel P, Akbar N, Pink RC, Carter DRF.

J Extracell Vesicles. 2017 Jul 3;6(1):1340746. doi: 10.1080/20013078.2017.1340746. eCollection 2017.

23.

Phenology of a Vegetation Barrier and Resulting Impacts on Near-Highway Particle Number and Black Carbon Concentrations on a School Campus.

Fuller CH, Carter DR, Hayat MJ, Baldauf R, Watts Hull R.

Int J Environ Res Public Health. 2017 Feb 8;14(2). pii: E160. doi: 10.3390/ijerph14020160.

24.

Isolation of Viable Glycosylation-Specific Cell Populations for Further In Vitro or In Vivo Analysis Using Lectin-Coated Magnetic Beads.

Beaman EM, Carter DR, Brooks SA.

Methods Mol Biol. 2017;1560:109-119. doi: 10.1007/978-1-4939-6788-9_7.

PMID:
28155148
25.

The Diagnostic and Prognostic Potential of microRNAs in Epithelial Ovarian Carcinoma.

Samuel P, Carter DR.

Mol Diagn Ther. 2017 Feb;21(1):59-73. doi: 10.1007/s40291-016-0242-z. Review.

PMID:
27718164
26.

Fetal Bovine Serum RNA Interferes with the Cell Culture derived Extracellular RNA.

Wei Z, Batagov AO, Carter DR, Krichevsky AM.

Sci Rep. 2016 Aug 9;6:31175. doi: 10.1038/srep31175.

27.

A novel compound which sensitizes BRAF wild-type melanoma cells to vemurafenib in a TRIM16-dependent manner.

Sutton SK, Carter DR, Kim P, Tan O, Arndt GM, Zhang XD, Baell J, Noll BD, Wang S, Kumar N, McArthur GA, Cheung BB, Marshall GM.

Oncotarget. 2016 Aug 9;7(32):52166-52178. doi: 10.18632/oncotarget.10700.

28.

Climate Change and Ecosystem Services Output Efficiency in Southern Loblolly Pine Forests.

Susaeta A, Adams DC, Carter DR, Dwivedi P.

Environ Manage. 2016 Sep;58(3):417-30. doi: 10.1007/s00267-016-0717-z. Epub 2016 Jun 4.

PMID:
27263100
29.

Glutathione biosynthesis is upregulated at the initiation of MYCN-driven neuroblastoma tumorigenesis.

Carter DR, Sutton SK, Pajic M, Murray J, Sekyere EO, Fletcher J, Beckers A, De Preter K, Speleman F, George RE, Haber M, Norris MD, Cheung BB, Marshall GM.

Mol Oncol. 2016 Jun;10(6):866-78. doi: 10.1016/j.molonc.2016.02.004. Epub 2016 Mar 2.

30.

miRNAs and ovarian cancer: a miRiad of mechanisms to induce cisplatin drug resistance.

Samuel P, Pink RC, Brooks SA, Carter DR.

Expert Rev Anticancer Ther. 2016;16(1):57-70. doi: 10.1586/14737140.2016.1121107. Epub 2015 Dec 5. Review.

PMID:
26567444
31.

RNAi2015 - Ten years of RNAi Oxford.

Bewicke-Copley F, Samuel P, Carter DR.

J RNAi Gene Silencing. 2015 Jul 21;11:515-8. eCollection 2015.

32.

Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma.

Carter DR, Murray J, Cheung BB, Gamble L, Koach J, Tsang J, Sutton S, Kalla H, Syed S, Gifford AJ, Issaeva N, Biktasova A, Atmadibrata B, Sun Y, Sokolowski N, Ling D, Kim PY, Webber H, Clark A, Ruhle M, Liu B, Oberthuer A, Fischer M, Byrne J, Saletta F, Thwe le M, Purmal A, Haderski G, Burkhart C, Speleman F, De Preter K, Beckers A, Ziegler DS, Liu T, Gurova KV, Gudkov AV, Norris MD, Haber M, Marshall GM.

Sci Transl Med. 2015 Nov 4;7(312):312ra176. doi: 10.1126/scitranslmed.aab1803.

33.

Over-expression of miR-31 or loss of KCNMA1 leads to increased cisplatin resistance in ovarian cancer cells.

Samuel P, Pink RC, Caley DP, Currie JM, Brooks SA, Carter DR.

Tumour Biol. 2016 Feb;37(2):2565-73. doi: 10.1007/s13277-015-4081-z. Epub 2015 Sep 19.

PMID:
26386726
34.

MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma.

Beckers A, Van Peer G, Carter DR, Gartlgruber M, Herrmann C, Agarwal S, Helsmoortel HH, Althoff K, Molenaar JJ, Cheung BB, Schulte JH, Benoit Y, Shohet JM, Westermann F, Marshall GM, Vandesompele J, De Preter K, Speleman F.

Cancer Lett. 2015 Sep 28;366(1):123-32. doi: 10.1016/j.canlet.2015.06.015. Epub 2015 Jun 26.

35.

Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma.

Cheung BB, Tan O, Koach J, Liu B, Shum MS, Carter DR, Sutton S, Po'uha ST, Chesler L, Haber M, Norris MD, Kavallaris M, Liu T, O'Neill GM, Marshall GM.

Mol Oncol. 2015 Aug;9(7):1484-500. doi: 10.1016/j.molonc.2015.04.005. Epub 2015 Apr 29.

36.

Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment.

Lambertz I, Kumps C, Claeys S, Lindner S, Beckers A, Janssens E, Carter DR, Cazes A, Cheung BB, De Mariano M, De Bondt A, De Brouwer S, Delattre O, Gibbons J, Janoueix-Lerosey I, Laureys G, Liang C, Marchall GM, Porcu M, Takita J, Trujillo DC, Van Den Wyngaert I, Van Roy N, Van Goethem A, Van Maerken T, Zabrocki P, Cools J, Schulte JH, Vialard J, Speleman F, De Preter K.

Clin Cancer Res. 2015 Jul 15;21(14):3327-39. doi: 10.1158/1078-0432.CCR-14-2024. Epub 2015 Mar 24.

37.

Social network approaches to leadership: an integrative conceptual review.

Carter DR, DeChurch LA, Braun MT, Contractor NS.

J Appl Psychol. 2015 May;100(3):597-622. doi: 10.1037/a0038922. Epub 2015 Mar 23. Review.

PMID:
25798551
38.

The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells.

Pink RC, Samuel P, Massa D, Caley DP, Brooks SA, Carter DR.

Gynecol Oncol. 2015 Apr;137(1):143-51. doi: 10.1016/j.ygyno.2014.12.042. Epub 2015 Jan 8.

PMID:
25579119
39.

TRIM16 inhibits proliferation and migration through regulation of interferon beta 1 in melanoma cells.

Sutton SK, Koach J, Tan O, Liu B, Carter DR, Wilmott JS, Yosufi B, Haydu LE, Mann GJ, Thompson JF, Long GV, Liu T, McArthur G, Zhang XD, Scolyer RA, Cheung BB, Marshall GM.

Oncotarget. 2014 Oct 30;5(20):10127-39.

40.

MYCN-targeting miRNAs are predominantly downregulated during MYCN‑driven neuroblastoma tumor formation.

Beckers A, Van Peer G, Carter DR, Mets E, Althoff K, Cheung BB, Schulte JH, Mestdagh P, Vandesompele J, Marshall GM, De Preter K, Speleman F.

Oncotarget. 2015 Mar 10;6(7):5204-16.

41.

Routes and mechanisms of extracellular vesicle uptake.

Mulcahy LA, Pink RC, Carter DR.

J Extracell Vesicles. 2014 Aug 4;3. doi: 10.3402/jev.v3.24641. eCollection 2014. Review.

42.

Improving the estimate of the effective elastic modulus derived from three-point bending tests of long bones.

Kourtis LC, Carter DR, Beaupre GS.

Ann Biomed Eng. 2014 Aug;42(8):1773-80. doi: 10.1007/s10439-014-1027-3. Epub 2014 May 21.

PMID:
24845868
43.

Art27 interacts with GATA4, FOG2 and NKX2.5 and is a novel co-repressor of cardiac genes.

Carter DR, Buckle AD, Tanaka K, Perdomo J, Chong BH.

PLoS One. 2014 Apr 17;9(4):e95253. doi: 10.1371/journal.pone.0095253. eCollection 2014.

44.

Sustainability of forest management under changing climatic conditions in the southern United States: adaptation strategies, economic rents and carbon sequestration.

Susaeta A, Carter DR, Adams DC.

J Environ Manage. 2014 Jun 15;139:80-7. doi: 10.1016/j.jenvman.2014.02.033. Epub 2014 Mar 27.

PMID:
24681367
45.

Cartilage nominal strain correlates with shear modulus and glycosaminoglycans content in meniscectomized joints.

Song Y, Carter DR, Giori NJ.

J Biomech Eng. 2014 Jun;136(6):064503. doi: 10.1115/1.4027298.

PMID:
24671447
46.

The prenatal origins of cancer.

Marshall GM, Carter DR, Cheung BB, Liu T, Mateos MK, Meyerowitz JG, Weiss WA.

Nat Rev Cancer. 2014 Apr;14(4):277-89. doi: 10.1038/nrc3679. Epub 2014 Mar 6. Review.

47.

Meta-analysis using a novel database, miRStress, reveals miRNAs that are frequently associated with the radiation and hypoxia stress-responses.

Jacobs LA, Bewicke-Copley F, Poolman MG, Pink RC, Mulcahy LA, Baker I, Beaman EM, Brooks T, Caley DP, Cowling W, Currie JM, Horsburgh J, Kenehan L, Keyes E, Leite D, Massa D, McDermott-Rouse A, Samuel P, Wood H, Kadhim M, Carter DR.

PLoS One. 2013 Nov 14;8(11):e80844. doi: 10.1371/journal.pone.0080844. eCollection 2013.

48.

Charting a course for collaboration: a multiteam perspective.

Asencio R, Carter DR, Dechurch LA, Zaccaro SJ, Fiore SM.

Transl Behav Med. 2012 Dec;2(4):487-94. doi: 10.1007/s13142-012-0170-3.

49.

RNAi2013: RNAi at Oxford.

Mulcahy LA, Carter DR.

J RNAi Gene Silencing. 2013 May 20;9:486-9. eCollection 2013. No abstract available.

50.

Pseudogenes as regulators of biological function.

Pink RC, Carter DR.

Essays Biochem. 2013;54:103-12. doi: 10.1042/bse0540103. Review.

PMID:
23829530

Supplemental Content

Loading ...
Support Center